103 related articles for article (PubMed ID: 19090715)
1. Exploring the pathogenesis of renal cell carcinoma: pathway and bioinformatics analysis of dysregulated genes and proteins.
Romaschin AD; Youssef Y; Chow TF; Siu KW; DeSouza LV; Honey RJ; Stewart R; Pace KT; Yousef GM
Biol Chem; 2009 Feb; 390(2):125-35. PubMed ID: 19090715
[TBL] [Abstract][Full Text] [Related]
2. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis.
Chow TF; Youssef YM; Lianidou E; Romaschin AD; Honey RJ; Stewart R; Pace KT; Yousef GM
Clin Biochem; 2010 Jan; 43(1-2):150-8. PubMed ID: 19646430
[TBL] [Abstract][Full Text] [Related]
3. Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma.
Seliger B; Lichtenfels R; Atkins D; Bukur J; Halder T; Kersten M; Harder A; Ackermann A; Malenica B; Brenner W; Zobawa M; Lottspeich F
Proteomics; 2005 Jul; 5(10):2631-40. PubMed ID: 15892167
[TBL] [Abstract][Full Text] [Related]
4. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
[TBL] [Abstract][Full Text] [Related]
5. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells.
Tang SW; Chang WH; Su YC; Chen YC; Lai YH; Wu PT; Hsu CI; Lin WC; Lai MK; Lin JY
Cancer Lett; 2009 Jan; 273(1):35-43. PubMed ID: 18809243
[TBL] [Abstract][Full Text] [Related]
6. Differential protein profiling in renal-cell carcinoma.
Shi T; Dong F; Liou LS; Duan ZH; Novick AC; DiDonato JA
Mol Carcinog; 2004 May; 40(1):47-61. PubMed ID: 15108329
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs.
White NM; Bui A; Mejia-Guerrero S; Chao J; Soosaipillai A; Youssef Y; Mankaruos M; Honey RJ; Stewart R; Pace KT; Sugar L; Diamandis EP; Doré J; Yousef GM
Biol Chem; 2010 Apr; 391(4):411-23. PubMed ID: 20180642
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel epigenetic markers for clear cell renal cell carcinoma.
Dalgin GS; Drever M; Williams T; King T; DeLisi C; Liou LS
J Urol; 2008 Sep; 180(3):1126-30. PubMed ID: 18639284
[TBL] [Abstract][Full Text] [Related]
9. The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma.
Faragalla H; Youssef YM; Scorilas A; Khalil B; White NM; Mejia-Guerrero S; Khella H; Jewett MA; Evans A; Lichner Z; Bjarnason G; Sugar L; Attalah MI; Yousef GM
J Mol Diagn; 2012 Jul; 14(4):385-92. PubMed ID: 22580180
[TBL] [Abstract][Full Text] [Related]
10. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
[TBL] [Abstract][Full Text] [Related]
11. Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling.
Furge KA; Tan MH; Dykema K; Kort E; Stadler W; Yao X; Zhou M; Teh BT
Oncogene; 2007 Feb; 26(9):1346-50. PubMed ID: 17322920
[TBL] [Abstract][Full Text] [Related]
12. Methylation-associated silencing of SFRP1 in renal cell carcinoma.
Awakura Y; Nakamura E; Ito N; Kamoto T; Ogawa O
Oncol Rep; 2008 Nov; 20(5):1257-63. PubMed ID: 18949430
[TBL] [Abstract][Full Text] [Related]
13. Molecular prognostic factor in renal cell carcinoma.
Shimazui T; Oosterwijk E; Debruyne FM; Schalken JA
Semin Urol Oncol; 1996 Nov; 14(4):250-5. PubMed ID: 8946626
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma.
Okamura N; Masuda T; Gotoh A; Shirakawa T; Terao S; Kaneko N; Suganuma K; Watanabe M; Matsubara T; Seto R; Matsumoto J; Kawakami M; Yamamori M; Nakamura T; Yagami T; Sakaeda T; Fujisawa M; Nishimura O; Okumura K
Proteomics; 2008 Aug; 8(15):3194-203. PubMed ID: 18615424
[TBL] [Abstract][Full Text] [Related]
16. Microarray analysis of microRNA expression in renal clear cell carcinoma.
Huang Y; Dai Y; Yang J; Chen T; Yin Y; Tang M; Hu C; Zhang L
Eur J Surg Oncol; 2009 Oct; 35(10):1119-23. PubMed ID: 19443172
[TBL] [Abstract][Full Text] [Related]
17. Expression of apoptotic tumour necrosis factor receptor-associated factor, caspase recruitment domain and cell death-inducing DFF-45 effector genes in therapy-treated renal cell carcinoma.
Rajandram R; Pat BK; Li J; Johnson DW; Gobe GC
Nephrology (Carlton); 2009 Apr; 14(2):205-12. PubMed ID: 19076291
[TBL] [Abstract][Full Text] [Related]
18. Molecular biology of renal cortical tumors.
Klatte T; Pantuck AJ
Urol Clin North Am; 2008 Nov; 35(4):573-80; vi. PubMed ID: 18992611
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics of hereditary renal cancer: new genes and diagnostic and therapeutic opportunities.
Hansel DE; Rini BI
Expert Rev Anticancer Ther; 2008 Jun; 8(6):895-905. PubMed ID: 18533799
[TBL] [Abstract][Full Text] [Related]
20. Characterization of HLA-G expression in renal cell carcinoma.
Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]